Efficacy of Muscle Energy Technique Alone and in Combination With Interferential Therapy for the Treatment of Non-specific Low Back Pain.

October 18, 2023 updated by: Neuro Counsel Hospital, Pakistan
Single blind randomized control trail in which two groups were formed. Group A was given Muscle energy technique and Group B was given muscle energy technique in combination with Interferential therapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After getting the REC approval from The Neurocounsel Clinics, study was initiated from 21 May, 2023 to 20 September 2023. Sample size was calculated by Epitool which came 30. Following participants were included a) both genders b) age 20-50 years and followings were excluded a) DM b) Parkinson disease c) disc disorder d) MSK disorder were excluded from this study. Simple random sampling technique was used to randomize participants into two equal groups. group A was given MET and group B was given MET plus IFT. 2 sessions/week for 4 & half weeks. Evaluation was done at PNS & EQ-5D-5L (QoL). Pre and post test analysis was done by use of SPSS version 21 and level of significance was kept p<0.05.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Federal
      • Islamabad, Federal, Pakistan, 44010
        • The Neurocouncil Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • both genders
  • age between 20-50 years old
  • non specific type of back pain

Exclusion Criteria:

  • Diabetes Mellitus
  • Parkinson disease
  • Any other Musculoskeletal disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Muscle energy technique was given to this group
Other: muscle energy technique
Muscle energy technique is used at a rate of three sessions per week for four and half weeks
Active Comparator: Group B
Muscle energy technique along with interferential therapy was given to this group
Other: Muscel energy technique along with interferential therapy
Muscle energy technique along with interferential therapy is used at a rate of three sessions per week for four and half weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain numeric scale
Time Frame: 4 and half weeks
this scale is used to measure the pain 0 means no pain and 10 means worst pain ever
4 and half weeks
short form of 36
Time Frame: 4 and half weeks
SF-36 is used to meaure the quality of life. 0 means worst quality of life and higher values towards 100 means best quality of life
4 and half weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Neuro Counsel Hospital, Pakistan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 21, 2023

Primary Completion (Actual)

September 20, 2023

Study Completion (Actual)

September 20, 2023

Study Registration Dates

First Submitted

October 18, 2023

First Submitted That Met QC Criteria

October 18, 2023

First Posted (Actual)

October 24, 2023

Study Record Updates

Last Update Posted (Actual)

October 24, 2023

Last Update Submitted That Met QC Criteria

October 18, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 348

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

have not decided anything yet

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe